Tenax Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 05/17/2024
Tenax Therapeutics Stock Forecast and Price Target
The average price target of $32.50 for Tenax Therapeutics's stock set by distinguished analysts in recent weeks would represent a potential upside of approximately 815.49% from the last closing price in May, 2024 if reached by the end of the year. This potential increase is based on a high estimate of $35.00 and a low estimate of $30.00. If you are looking to invest in the stock, it's important to research and compare different companies.
815.49% Upside
Tenax Therapeutics Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Tenax Therapeutics's Price has grown from $0.00 to $0.00 – a 100.00% increase. Next year, analysts are expecting Fair Value to reach $3.80 – an increase of 100.00%. Over the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ABBV Stock Forecast | AbbVie | Outperform |
9
|
$164.35 | Buy/Sell | $178.42 | 9.52% |
| AMGN Stock Forecast | Amgen | Outperform |
4
|
$314.72 | Buy/Sell | $303.65 | 1.68% |
| GILD Stock Forecast | Gilead Sciences Inc | Outperform |
11
|
$67.86 | Buy/Sell | $87.82 | 17.89% |
| ALXN Stock Forecast | Alexion Pharmaceuticals | - |
0
|
$182.50 | Buy/Sell | $177.38 | -100.00% |
| BIIB Stock Forecast | Biogen | Outperform |
10
|
$230.04 | Buy/Sell | $299.62 | 25.41% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BMRN Stock Forecast | BioMarin Pharmaceutical | Outperform |
10
|
$76.97 | Buy/Sell | $111.56 | 43.56% |
| INCY Stock Forecast | Incyte | Outperform |
9
|
$56.86 | Buy/Sell | $77.05 | 38.06% |
| VKTX Stock Forecast | Viking Therapeutics | Buy |
5
|
$69.06 | Buy/Sell | $34.00 | 66.52% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BPMC Stock Forecast | Blueprint Medicines | Outperform |
6
|
$106.64 | Buy/Sell | $85.71 | 12.53% |
| ARNA Stock Forecast | Arena Pharmaceuticals | - |
6
|
$99.99 | Buy/Sell | $100.00 | -100.00% |
| IOVA Stock Forecast | Iovance Biotherapeutics | Buy |
4
|
$10.43 | Buy/Sell | $20.42 | 139.69% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CCXI Stock Forecast | ChemoCentryx | - |
8
|
$51.99 | Buy/Sell | $52.00 | -100.00% |
| CBAY Stock Forecast | CymaBay Therapeutics | Hold |
8
|
$32.44 | Buy/Sell | $27.73 | -100.00% |
| ARWR Stock Forecast | Arrowhead Pharmaceuticals | Outperform |
7
|
$25.00 | Buy/Sell | $52.00 | 120.00% |
Tenax Therapeutics EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Tenax Therapeutics's EBITDA has seen a drop from $-9.86M to $-8.23M – a 16.53% decrease. In the next year, analysts believe that EBITDA will reach $-12.37M – an increase of 50.26%. For the next seven years, the forecast is for EBITDA to grow by 102.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DRNA Stock Forecast | Dicerna Pharmaceuticals | - |
7
|
$38.01 | Buy/Sell | $35.06 | -100.00% |
| FOLD Stock Forecast | Amicus Therapeutics | Outperform |
7
|
$9.50 | Buy/Sell | $17.90 | 89.47% |
| CLDX Stock Forecast | Celldex Therapeutics | Buy |
11
|
$39.94 | Buy/Sell | $63.29 | 77.77% |
Tenax Therapeutics EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Tenax Therapeutics's EBIT has gone down from $-9.87M to $-8.23M – a 16.62% drop. In the next year, analysts believe that EBIT will reach $-12.03M – an increase of 46.17%. According to professional forecasts, in 2030, Tenax Therapeutics's EBIT will decrease by 5279.47%, reaching $426.27M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ACAD Stock Forecast | ACADIA Pharmaceuticals | Outperform |
6
|
$14.85 | Buy/Sell | $33.78 | 88.55% |
| VCEL Stock Forecast | Vericel | Buy |
8
|
$47.61 | Buy/Sell | $42.58 | 17.62% |
| ADMA Stock Forecast | ADMA Biologics | Buy |
9
|
$9.06 | Buy/Sell | $6.00 | 10.38% |
Tenax Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Tenax Therapeutics's EPS has grown from $-2128.00 to $0.00 – a 100.00% increase. Next year, analysts are expecting EPS to reach $-0.30 – an increase of 100.00%. Over the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ARDX Stock Forecast | Ardelyx | Buy |
11
|
$7.79 | Buy/Sell | $9.94 | 79.72% |
| AGIO Stock Forecast | Agios Pharmaceuticals | Outperform |
9
|
$35.00 | Buy/Sell | $40.00 | 27.14% |
| DVAX Stock Forecast | Dynavax Technologies | Outperform |
11
|
$11.28 | Buy/Sell | $25.00 | 121.63% |
.jpg)